Table 2 Patients and lymph node characteristics
Participan | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | 60 | 52 | 61 | 65 | 68 | 53 | 54 | 68 | 55 | |
BMI (kg/m2) | 31,6 | 30,4 | 26,4 | 29,4 | 25,4 | 20,2 | 28,3 | 31,5 | 43,9 | |
Tumour type | Invasive NST | Invasive NST | Invasive NST | DCIS gr2 | Invasive NST | Invasive NST | Invasive Lobular | Invasive NST | Invasive NST | |
Tumour location |
|
|
|
|
|
|
|
|
| |
SPIO Injection site | Latero cranial | Latero cranial | dorsal | dorsal | dorsal | dorsal | dorsal | dorsal | dorsal | |
Interval SPIO-SLNB (days) | 8 | 4 | 3 | 3 | 2 | 5 | 1 | 2 | 1 | |
Patent Blue (yes/no) | yes | yes | yes | yes | yes | no | no | yes | yes | |
Resected SLN | 2 | 1 | 2 | 1 | 3 | 5 | 2 | 2 | 2 | |
Tumour stage | pT2n0 | pT1N0 | pT1N0 | pTisN0 | pT1N1(mi) | pT1N0 | pT3N1a | pT2N0 | pT1N0 | |
Metastases size (mm) | ITC | 1.6 | 2.4 | |||||||
Iron content per Lymph node (μg)a | 1 2 3 4 5 | 46,47 0,81 | 0,0001 | 84,15 81,94 | 93,91 | 2,59 11,45 52,24 | 6,58 18,10 9,24 11,90 5,69 | 108,98 30,52 | 19,88 20,76 | 61,55 18,55 |
TC counts gammaprobe | 1 2 3 4 5 | 140 3000 | 250 | 1425 638 | 2000 | 70 400 490 | 1040 5 5 2200 1100 | 9900 1400 | 240 12 | 10,400 5200 |
